Cargando…
Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts
The perturbations of the gut microbiota and metabolites are closely associated with the progression of inflammatory bowel disease (IBD). However, inconsistent findings across studies impede a comprehensive understanding of their roles in IBD and their potential as reliable diagnostic biomarkers. To...
Autores principales: | Ning, Lijun, Zhou, Yi-Lu, Sun, Han, Zhang, Youwei, Shen, Chaoqin, Wang, Zhenhua, Xuan, Baoqin, Zhao, Ying, Ma, Yanru, Yan, Yuqing, Tong, Tianying, Huang, Xiaowen, Hu, Muni, Zhu, Xiaoqiang, Ding, Jinmei, Zhang, Yue, Cui, Zhe, Fang, Jing-Yuan, Chen, Haoyan, Hong, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628233/ https://www.ncbi.nlm.nih.gov/pubmed/37932270 http://dx.doi.org/10.1038/s41467-023-42788-0 |
Ejemplares similares
-
Commensal bacteria promote azathioprine therapy failure in inflammatory bowel disease via decreasing 6-mercaptopurine bioavailability
por: Yan, Yuqing, et al.
Publicado: (2023) -
Identification and investigation of depression-related molecular subtypes in inflammatory bowel disease and the anti-inflammatory mechanisms of paroxetine
por: Ning, Lijun, et al.
Publicado: (2023) -
ALKBH4 Functions as a Suppressor of Colorectal Cancer Metastasis via Competitively Binding to WDR5
por: Shen, Chaoqin, et al.
Publicado: (2020) -
m(6)A-dependent glycolysis enhances colorectal cancer progression
por: Shen, Chaoqin, et al.
Publicado: (2020) -
CCMAlnc Promotes the Malignance of Colorectal Cancer by Modulating the Interaction Between miR-5001-5p and Its Target mRNA
por: Yan, Yuqing, et al.
Publicado: (2020)